{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 50.29,
  "market_cap": 223462588416,
  "revenue_ttm": 49536502216.25083,
  "net_income_ttm": 16288030989.84166,
  "ocf_ttm": 19428923015.105663,
  "capex_ttm": 9862316201.860897,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1393632516.731752,
  "total_debt": 15886374766.13217,
  "cash_and_equivalents": 5114171448.662087,
  "book_value_ttm": 26666582955.587086,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4557052,
  "dividend_yield": 343.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-12T12:42:15Z"
}